TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
INVA

Innoviva Inc

Healthcare · Biotechnology

20.70$ +0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Innoviva Inc (INVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,635 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INVA
Line item 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
247 – 193 125 286 225 262 162 236 181 331 259 369 681 522 424 379 367 548 725 1,000 926 1,231 1,244 1,301 1,635
– – 152 91 264 167 207 134 210 162 316 245 261 483 252 214 198 200 199 431 342 314 444 344 554 728
– – 109 36 101 50 72 86 92 48 163 45 95 144 97 159 118 73 62 278 246 202 291 194 305 551
– – 149 89 257 162 201 127 201 155 310 241 248 465 240 187 150 129 115 351 246 202 291 194 412 551
– – 1.5 0.4 2.1 1.0 1.7 0.5 0.6 0.4 0.2 0.3 1.1 3.4 11 26 47 71 83 79 94 111 64 84 86 35
– – – – – – – 4.4 5.6 3.4 1.7 0.0 7.5 10 0.0 -26 -47 -0.8 -83 -79 -94 -111 56 41 34 39
– – 20 16 13 13 15 20 16 13 10 10 9.2 10 0.3 0.2 0.4 0.2 0.2 0.0 0.0 0.0 3.4 – – –
– – – – – – – – – – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – 101 27 18 18 18
– – – – – – – – – – – 0.0 0.0 124 0.3 194 181 167 153 139 94 10 253 230 208 182
23 – 425 425 96 165 199 228 371 370 354 346 214 382 745 752 732 610 389 383 392 400 666 569 610 462
– – 39 20 35 48 60 56 44 39 40 45 30 84 14 13 20 35 5.7 5.4 6.1 5.8 135 38 236 50
– – 28 3.5 2.6 1.2 0.1 0.1 0.1 0.2 0.2 0.1 – – 726 6.2 7.8 25 – – 25 0.1 98 1.2 194 0.4
– – 1.6 3.2 5.9 8.1 16 7.0 3.3 1.8 2.1 5.8 5.4 7.6 0.0 0.8 0.1 0.6 0.0 0.0 0.1 0.0 2.9 6.7 2.1 5.0
– – 7.9 4.4 1.8 0.6 0.5 0.4 173 173 173 173 173 288 726 733 708 574 383 377 386 395 540 446 256 258
224 – -232 -300 190 60 63 -66 -135 -189 -22 -87 155 299 -223 -343 -353 -243 154 313 608 415 566 675 691 1,173
-151 – -295 -366 -469 -612 -778 -938 -1,031 -1,117 -1,201 -1,316 -1,335 -1,505 -1,674 -1,692 -1,633 -1,499 -1,104 -946 -722 -456 -205 -25 -1.8 269
3.8 5.5 6.3 6.8 33 53 59 60 61 63 72 82 91 102 112 115 123 120 113 113 114 94 95 87 74 85

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?